DK163689A - Peptidderivater - Google Patents

Peptidderivater

Info

Publication number
DK163689A
DK163689A DK163689A DK163689A DK163689A DK 163689 A DK163689 A DK 163689A DK 163689 A DK163689 A DK 163689A DK 163689 A DK163689 A DK 163689A DK 163689 A DK163689 A DK 163689A
Authority
DK
Denmark
Prior art keywords
peptide derivatives
peptide
derivatives
Prior art date
Application number
DK163689A
Other languages
Danish (da)
English (en)
Other versions
DK163689D0 (da
Inventor
Rainer Albert
Wilfried Bauer
Francois Cardinaux
Janos Pless
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888808275A external-priority patent/GB8808275D0/en
Priority claimed from GB888808528A external-priority patent/GB8808528D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK163689D0 publication Critical patent/DK163689D0/da
Publication of DK163689A publication Critical patent/DK163689A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK163689A 1988-04-08 1989-04-05 Peptidderivater DK163689A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888808275A GB8808275D0 (en) 1988-04-08 1988-04-08 New calcitonin derivatives
GB888808528A GB8808528D0 (en) 1988-04-12 1988-04-12 Peptide derivatives

Publications (2)

Publication Number Publication Date
DK163689D0 DK163689D0 (da) 1989-04-05
DK163689A true DK163689A (da) 1989-10-30

Family

ID=26293749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK163689A DK163689A (da) 1988-04-08 1989-04-05 Peptidderivater

Country Status (19)

Country Link
US (1) US5541159A (cs)
JP (2) JPH01305099A (cs)
AT (1) ATA900689A (cs)
AU (2) AU3362889A (cs)
BE (1) BE1004357A4 (cs)
CH (1) CH682152A5 (cs)
DK (1) DK163689A (cs)
ES (1) ES2015645A6 (cs)
FR (1) FR2629825B1 (cs)
GB (1) GB2218102B (cs)
IE (1) IE930109L (cs)
IL (1) IL89881A (cs)
IT (1) IT1235894B (cs)
LU (1) LU87495A1 (cs)
MY (1) MY108554A (cs)
NL (1) NL8900864A (cs)
NZ (1) NZ228677A (cs)
SE (1) SE8901241L (cs)
WO (1) WO1989009786A1 (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2218102B (en) * 1988-04-08 1992-09-16 Sandoz Ltd Calcitonin peptide derivatives
DE3842010A1 (de) * 1988-12-14 1990-06-21 Hoechst Ag Kompetitive gonadoliberin-antagonisten
US5364840A (en) * 1989-12-05 1994-11-15 Vical, Inc. Synthetic calcitonin peptides
DE59100945D1 (de) * 1990-08-04 1994-03-10 Hoechst Ag Gonadoliberin-Antagonisten.
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
EP0632813B1 (en) * 1992-02-13 1999-12-15 Torf Establishment Amadori reaction compounds and products, process for their manufacture, and their use
JPH07506344A (ja) * 1992-02-13 1995-07-13 トルフ　エスタブリッシュメント アマドリ反応化合物と生産物、その製造プロセスとその使用
FR2695391B1 (fr) * 1992-09-04 1994-10-14 Centre Nat Rech Scient Glycopeptides, leur procédé d'obtention, et leurs applications biologiques.
CA2123144A1 (en) * 1993-05-10 1994-11-11 David Bodmer Stabilisation of pharmacologically active compounds in sustained release compositions
EP0698040A4 (en) * 1993-05-20 1999-01-07 Biotech Australia Pty Ltd LHRH ANTAGONISTS
ATE399177T1 (de) * 1993-08-09 2008-07-15 Sod Conseils Rech Applic Derivate therapeutischer peptide
US5698521A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Native calcitonin mimetics
US5698672A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Synthetic calcitonin mimetics
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
US6239108B1 (en) 1996-07-11 2001-05-29 Biogen, Inc. Cell adhesion inhibitors
JP2002515043A (ja) 1996-07-25 2002-05-21 バイオジェン，インコーポレイテッド Ｖｌａ―４インヒビターのための分子モデル
US6686350B1 (en) 1996-07-25 2004-02-03 Biogen, Inc. Cell adhesion inhibitors
US6083480A (en) * 1997-05-01 2000-07-04 Diatide, Inc. Calcitonin receptor binding reagents
DE69943039D1 (de) * 1998-02-13 2011-01-27 Amylin Pharmaceuticals Inc Neue verbindungen mit gemischter amylin aktivität
ES2211096T3 (es) 1998-05-28 2004-07-01 Biogen, Inc. Un inhibidor de vla-4: omepupa-v.
US6630503B1 (en) 1999-08-13 2003-10-07 Biogen, Inc. Cell adhesion inhibitors
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
US6875743B1 (en) 2000-11-28 2005-04-05 Biogen, Inc. Cell adhesion inhibitors
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7196112B2 (en) 2004-07-16 2007-03-27 Biogen Idec Ma Inc. Cell adhesion inhibitors
JP6265583B2 (ja) 2008-10-17 2018-01-24 ウィスコンシン アルムニ リサーチ ファンデイション 生理活性アルファベータペプチドを作製する方法
GB201813677D0 (en) * 2018-08-22 2018-10-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
TW202320857A (zh) * 2021-07-06 2023-06-01 美商普方生物製藥美國公司 連接子、藥物連接子及其結合物及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956260A (en) * 1967-11-09 1976-05-11 Ciba-Geigy Corporation Hypocalcaemic peptides and processes for their manufacture
JPS51128993A (en) * 1975-05-01 1976-11-10 Tanpakushitsu Kenkyu Shiyoureikai Process for preparing new polypeptides
US4650854A (en) * 1985-06-06 1987-03-17 Usv Pharmaceutical Corporation Amide analogs of calcitonin
HUT44794A (en) * 1985-12-04 1988-04-28 Sandoz Ag Process for production of calcitonine-derivatives and medical preparatives containing such compounds
DE3634435A1 (de) * 1986-10-09 1988-04-14 Hoechst Ag Analoga von gonadoliberin mit verbesserter loeslichkeit, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
HU206890B (en) * 1986-10-13 1993-01-28 Sandoz Ag Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components
GB2218102B (en) * 1988-04-08 1992-09-16 Sandoz Ltd Calcitonin peptide derivatives

Also Published As

Publication number Publication date
NZ228677A (en) 1994-08-26
IE930109L (en) 1989-10-08
US5541159A (en) 1996-07-30
AU3362889A (en) 1989-11-03
NL8900864A (nl) 1989-11-01
AU3263789A (en) 1989-10-12
FR2629825A1 (fr) 1989-10-13
SE8901241L (sv) 1990-02-02
DK163689D0 (da) 1989-04-05
JPH0789994A (ja) 1995-04-04
AU623385B2 (en) 1992-05-14
IL89881A0 (en) 1989-12-15
GB8907652D0 (en) 1989-05-17
ES2015645A6 (es) 1990-09-01
BE1004357A4 (fr) 1992-11-10
GB2218102B (en) 1992-09-16
JPH01305099A (ja) 1989-12-08
CH682152A5 (cs) 1993-07-30
LU87495A1 (fr) 1989-11-14
IT1235894B (it) 1992-11-23
WO1989009786A1 (en) 1989-10-19
MY108554A (en) 1996-10-31
FR2629825B1 (fr) 1993-05-14
ATA900689A (de) 1997-01-15
SE8901241D0 (sv) 1989-04-07
GB2218102A (en) 1989-11-08
IL89881A (en) 1994-05-30
IT8947823A0 (it) 1989-04-07

Similar Documents

Publication Publication Date Title
DK612689D0 (da) Peptidderivater
DK163689A (da) Peptidderivater
DK22588A (da) Peptidderivater
DK532787D0 (da) Peptidderivater
FI900864A7 (fi) Glysiinijohdannaiset
DK540289A (da) Protein
DK149889A (da) Soedemiddel
DE68927948D1 (de) Trehalosderivate
DE68925161D1 (de) Alkylavermectin-Derivate
DK375789D0 (da) Peptidderivater
DK19789D0 (da) Dehydrocholcalciferolderivater
DE68927657D1 (de) Butynylaminderivate
DK197989A (da) Peptidanaloger
FI891581A7 (fi) Peptidderivat.
DK486089D0 (da) Pyranobenzoxadiazolderivater
DK301889A (da) Peptidderivater
DK395288D0 (da) Proteiner
FI91488B (fi) Seula
DK177789D0 (da) Peptidderivater
KR900700503A (ko) 펩티드
DK4390D0 (da) Peptidderivater
DK160389A (da) Aryldionderivater
FI912412A7 (fi) HDL-sitovat proteiinit
DK657189A (da) Peptidderivater
ATA155589A (de) Mitomycinphosphat-derivate

Legal Events

Date Code Title Description
PBP Patent lapsed
AHB Application shelved due to non-payment